Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus
- PMID: 17940972
- DOI: 10.1086/520613
Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus
Abstract
Blood samples from patients infected with the Sudan species of Ebola virus (EBOV), obtained during an outbreak of disease in Uganda in 2000, were tested for a panel of analytes to evaluate their clinical condition and to compare values obtained for patients with fatal and nonfatal cases and for uninfected (hospitalized control) patients. Liver function tests showed higher levels of aspartate aminotransferase (AST) in blood samples from patients with fatal cases than in samples from patients with nonfatal cases, whereas alanine aminotransferase levels were comparable and only slightly increased in all patients, suggesting that increased blood AST levels are due to a greater degree of injury in tissues other than the liver. Significantly higher levels of amylase, urea nitrogen, and creatinine suggest that acute pancreatitis and renal dysfunction develop in fatal cases, whereas reduced albumin and calcium levels may be linked to these conditions or to liver damage. d-Dimer levels in blood specimens were drastically increased in patients with fatal and nonfatal infections but were 4 times higher in patients with fatal cases than in patients who survived (180,000 vs. 44,000 ng/mL), during the most acute period of the infection (6-8 days after onset). These results indicate that disseminated intravascular coagulation is an early and important component of EBOV disease. This study has identified levels of analytes with prognostic value, which can also be used to target therapeutic interventions, and expands on the findings of prior blood tests conducted on this group of patients.
Similar articles
-
Cytokine and chemokine expression in humans infected with Sudan Ebola virus.J Infect Dis. 2007 Nov 15;196 Suppl 2:S357-63. doi: 10.1086/520611. J Infect Dis. 2007. PMID: 17940971
-
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.J Virol. 2004 Oct;78(19):10370-7. doi: 10.1128/JVI.78.19.10370-10377.2004. J Virol. 2004. PMID: 15367603 Free PMC article.
-
Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004.J Infect Dis. 2007 Nov 15;196 Suppl 2:S193-8. doi: 10.1086/520609. J Infect Dis. 2007. PMID: 17940949
-
Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.Bull Soc Pathol Exot. 2005 Sep;98(3):210-7. Bull Soc Pathol Exot. 2005. PMID: 16267963 Review.
-
Ebola virus: unravelling pathogenesis to combat a deadly disease.Trends Mol Med. 2006 May;12(5):206-15. doi: 10.1016/j.molmed.2006.03.006. Epub 2006 Apr 17. Trends Mol Med. 2006. PMID: 16616875 Review.
Cited by
-
Rhabdomyolysis, Acute Kidney Injury, and Mortality in Ebola Virus Disease: Retrospective Analysis of Cases From the Eastern Democratic Republic of the Congo, 2019.J Infect Dis. 2024 Aug 16;230(2):e465-e473. doi: 10.1093/infdis/jiae224. J Infect Dis. 2024. PMID: 38696335 Free PMC article.
-
Ebola virus infection induces a delayed type I IFN response in bystander cells and the shutdown of key liver genes in human iPSC-derived hepatocytes.Stem Cell Reports. 2022 Oct 11;17(10):2286-2302. doi: 10.1016/j.stemcr.2022.08.003. Epub 2022 Sep 8. Stem Cell Reports. 2022. PMID: 36084636 Free PMC article.
-
A drug-disease model for predicting survival in an Ebola outbreak.Clin Transl Sci. 2022 Oct;15(10):2538-2550. doi: 10.1111/cts.13383. Epub 2022 Aug 17. Clin Transl Sci. 2022. PMID: 35895082 Free PMC article.
-
Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques.Emerg Microbes Infect. 2022 Dec;11(1):1635-1646. doi: 10.1080/22221751.2022.2086072. Emerg Microbes Infect. 2022. PMID: 35657325 Free PMC article.
-
Platelets in Viral Infections - Brave Soldiers or Trojan Horses.Front Immunol. 2022 Mar 28;13:856713. doi: 10.3389/fimmu.2022.856713. eCollection 2022. Front Immunol. 2022. PMID: 35419008 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical